Anthrax vaccine adsorbed adjuvanted - Emergent BioSolutions
Alternative Names: AV 7909; AV7909 Anthrax Vaccine Adsorbed; BioThrax + agatolimod; CYFENDUS; NuThrax; Third-generation anthrax vaccine candidate (BioThrax + CPG 7909) - Emergent BioSolutionsLatest Information Update: 11 Nov 2025
At a glance
- Originator Emergent BioSolutions
- Developer Biomedical Advanced Research and Development Authority; Emergent BioSolutions
- Class Anthrax vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Yes - Anthrax
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Anthrax